Market News

Arcutis Biotherapeutics (ARQT) drew investor attention after reporting third quarter 2026 earnings, with net product revenue for ZORYVE up 45% year ov...

-CNBC.

Cresco Labs (OTC:CRLBF) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been pro...

Cogent Biosciences (COGT) reported widening third quarter losses and a busy regulatory calendar, posting a net loss of US$111.43 million as it approac...

AI related shares have just been hit by one of their worst sell offs since 2020 after concerns that new Democratic lawmakers could slow data centre ro...

Piper Sandler analyst Michael Lavery maintains Kimberly-Clark (NASDAQ:KMB) with a Overweight and raises the price target from $118 to $137.

Anika Therapeutics (NASDAQ:ANIK) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has...

MACOM Technology Solutions Holdings (MTSI) has released fourth quarter results for the period ending October 2, 2026, reporting sales of US$424.82 mil...

Why MannKind’s latest quarter is drawing attention MannKind (MNKD) just released its third quarter numbers, reporting higher revenue along with a shif...

Wells Fargo analyst Noah Hungness maintains Chord Energy (NASDAQ:CHRD) with a Overweight and lowers the price target from $174 to $173.

VEON raises mid-point of 2026 Revenue and EBITDA outlook Key Highlights Total revenue increased 17.2% YoY to USD 1,307 million. Revenue for 9M26 grew ...

Hershey shares have climbed 12.8% over the past five years, and the recent rebound in 2026 now puts a sharper spotlight on whether the current US$177....

Keybanc analyst Ken Newman maintains Cognex (NASDAQ:CGNX) with a Overweight and lowers the price target from $80 to $65.

Piper Sandler analyst Bill Carcache maintains Affirm Holdings (NASDAQ:AFRM) with a Overweight and lowers the price target from $115 to $105.

(Updates with information on Microsoft delivery delays in the headline and the fifth to seventh para

ADMA Biologics reported third quarter 2026 sales of US$141.1 million and net income of US$49.88 million, with basic earnings per share from continuing...

Wall Street's biggest trading desks spent weeks arguing that the stock-market rally would resume once the election was over. On Thursday, that call ba...

Etsy (NYSE: ETSY) announced that Chief Financial Officer Lanny Baker will depart the company, and a transition is already underway. The marketplace op...

Coeur Mining is a Strong Buy, driven by substantial production growth projects and a favorable North American operating landscape. Click for more on C...

Piper Sandler analyst James Fish reiterates Cloudflare (NYSE:NET) with a Overweight and raises the price target from $333 to $337.